Category Biology/Biotechnology

Antioxidants can Double the rate of Melanoma Metastasis in mice, new research shows

The results reinforce previous findings that antioxidants hasten the progression of lung cancer. People with cancer or an elevated risk of developing the disease should avoid nutritional supplements that contain antioxidants, the researchers say. Given well-established evidence that free radicals can cause cancer, the research community had simply assumed that antioxidants, which destroy them, provide protection against the disease.

“As opposed to the lung cancer studies, the primary melanoma tumor was not affected,” Professor Bergö says. “But the antioxidant boosted the ability of the tumor cells to metastasize, an even more serious problem because metastasis is the cause of death in the case of melanoma. The primary tumor is not dangerous per se and is usually removed.”

Experiments ...

Read More

Disabling erbB Pathway + IFN-γ Therapy Eradicates a Breast Cancer type in mice

Highlights •IFN-γ and 4D5 act directly on erbB2-positive breast cancer cells •IFN-γ, but not IFN-α or β, cooperates with 4D5 directly on erbB2+ breast cancer cells •IFN-γ and 4D5 alters KLF4 levels and degrades Snail by the GSK3-β/proteasome pathway •Sequential combination treatment with mAb and IFN-γ sensitizes for tumor eradication

Highlights •IFN-γ and 4D5 act directly on erbB2-positive breast cancer cells •IFN-γ, but not IFN-α or β, cooperates with 4D5 directly on erbB2+ breast cancer cells •IFN-γ and 4D5 alters KLF4 levels and degrades Snail by the GSK3-β/proteasome pathway •Sequential combination treatment with mAb and IFN-γ sensitizes for tumor eradication. Credit: http://dx.doi.org/10.1016/j.celrep.2015.08.044

This therapy, when translated for use in people humans, would be beneficial in reducing toxicity because the amount of antibody could be decreased by 2/3 and the amount of chemotherapy by at least 1/2, they say. This in turn, “reduces the cost of treatment so that individuals previously not able to afford targeted therapy will be able to do so.

“This line of research is important to future ...

Read More

Groundbreaking Computer Program Diagnoses Cancer in 2 days

Groundbreaking computer program diagnoses cancer in two days

Groundbreaking computer program diagnoses cancer in two days

In 1 in 20 cancer cases, the doctor can confirm that the patient has cancer – but cannot find the source. These patients then face the prospect of a long wait with numerous diagnostic tests and attempts to locate the origin of the cancer before starting any treatment. Now, researchers have combined genetics with computer science and created a new diagnostic technology based on advanced self-learning computer algorithms which can, with 85% certainty, identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.

Each year, ~35,000 people are diagnosed with cancer in Denmark, and many of them face the prospect of a long wait until the cancer has been diagnosed and its source loc...

Read More

Melatonin and mealtime: Common genetic difference could put some at greater risk of Diabetes

Distribution of the 40 nonsynonymous MT2 variants identified by exon resequencing.

Distribution of the 40 nonsynonymous MT2 variants identified by exon resequencing.

New light has been shed on why people who carry a common genetic melatonin receptor mutation may be more at risk for developing type 2 diabetes. By carefully studying healthy subjects, researchers were able to chart the effect of melatonin supplements on blood sugar control. Their results suggest that taking melatonin close to mealtimes may put people with a common genetic variant more at risk.

As many as 50% of people of European ancestry carry this genetic variation in MTNR1B, a gene that encodes a melatonin receptor...

Read More